Influence of ZP2 peptide, a synthetic analogue of the GM-GSF active center on the anticytokine activity of bacteria from Enterococcus genus and their ability to produce cytokine-like substances

O. A. Pashinina, O. L. Kartashova, T. M. Pashkova, V. Gritsenko
{"title":"Influence of ZP2 peptide, a synthetic analogue of the GM-GSF active center on the anticytokine activity of bacteria from Enterococcus genus and their ability to produce cytokine-like substances","authors":"O. A. Pashinina, O. L. Kartashova, T. M. Pashkova, V. Gritsenko","doi":"10.46235/1028-7221-1162-ioz","DOIUrl":null,"url":null,"abstract":"Peptide ZP2, a synthetic analogue of the active center of granulocyte-macrophage colony stimulating factor (GM-CSF), exhibits a wide range of immunobiological effects, including antibacterial activity. At the same time, its effect (in sub-inhibitory concentrations) on the biological properties of Enterococcus spp., the causative agents of many infectious and inflammatory diseases remains poorly understood. The aim of our study was to analyze the nature of the effect of synthetic peptide ZP2 on anticytokine activity (ACA) and its ability to produce cytokine-like substances (CLS) in Enterococcus spp. \n18 clinical isolates of Enterococcus spp. were used. Over the experiments, the bacterial strains were cultured in Schaedlers broth with ZP2 peptide at 37 C for 24 hours. No specific peptide was added in the control. ACA for IL-8, TNF and IL-17A and the production of the corresponding CLS were determined by the ELISA method. To assess ACA, the proportion of cytokine inactivation in the experiment relative to the control was calculated and expressed in pg/ml; CLS production was evaluated by the level of cytokines in the experiment and control, expressed as pg/ml. The data were subjected to statistical processing. \nIt was revealed that Enterococcus spp. strains are capable of secreting compounds that inactivate cytokines IL-8, IL-17A and TNF, and produce CLS in the culture medium. Intragenital and intraspecific variability was noted in the presence and frequency of occurrence and in the severity of these properties. It was found that the ZP2 peptide in E. faecium increases ACA with respect to all studied cytokines. When tested with E. faecalis, it either did not affect their ACA against TNF and IL-8, or completely inhibited ACA for IL-17A. At the same time, ZP2 blocked the production of CLS, e.g., IL-17A and IL-8 in E. faecium, but increased the production of CLS similar to TNF, and, with E. faecalis, it increased the number of IL-17A-producing isolates twofold, although the average level of production of these CLS was lower than in the control. \nEnterococcus spp strains are capable of secreting compounds that inactivate cytokines IL-8, TNF and IL- 17A, and may produce substances similar to these cytokines. The synthetic peptide ZP2 has a modifying effect on the manifestation of these properties by Enterococci. Further studies of biological and pathogenetic features of Enterococci and other bacterial species, as well as modifying effects of the ZP2 peptide are required.","PeriodicalId":21524,"journal":{"name":"Russian Journal of Immunology","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46235/1028-7221-1162-ioz","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Peptide ZP2, a synthetic analogue of the active center of granulocyte-macrophage colony stimulating factor (GM-CSF), exhibits a wide range of immunobiological effects, including antibacterial activity. At the same time, its effect (in sub-inhibitory concentrations) on the biological properties of Enterococcus spp., the causative agents of many infectious and inflammatory diseases remains poorly understood. The aim of our study was to analyze the nature of the effect of synthetic peptide ZP2 on anticytokine activity (ACA) and its ability to produce cytokine-like substances (CLS) in Enterococcus spp. 18 clinical isolates of Enterococcus spp. were used. Over the experiments, the bacterial strains were cultured in Schaedlers broth with ZP2 peptide at 37 C for 24 hours. No specific peptide was added in the control. ACA for IL-8, TNF and IL-17A and the production of the corresponding CLS were determined by the ELISA method. To assess ACA, the proportion of cytokine inactivation in the experiment relative to the control was calculated and expressed in pg/ml; CLS production was evaluated by the level of cytokines in the experiment and control, expressed as pg/ml. The data were subjected to statistical processing. It was revealed that Enterococcus spp. strains are capable of secreting compounds that inactivate cytokines IL-8, IL-17A and TNF, and produce CLS in the culture medium. Intragenital and intraspecific variability was noted in the presence and frequency of occurrence and in the severity of these properties. It was found that the ZP2 peptide in E. faecium increases ACA with respect to all studied cytokines. When tested with E. faecalis, it either did not affect their ACA against TNF and IL-8, or completely inhibited ACA for IL-17A. At the same time, ZP2 blocked the production of CLS, e.g., IL-17A and IL-8 in E. faecium, but increased the production of CLS similar to TNF, and, with E. faecalis, it increased the number of IL-17A-producing isolates twofold, although the average level of production of these CLS was lower than in the control. Enterococcus spp strains are capable of secreting compounds that inactivate cytokines IL-8, TNF and IL- 17A, and may produce substances similar to these cytokines. The synthetic peptide ZP2 has a modifying effect on the manifestation of these properties by Enterococci. Further studies of biological and pathogenetic features of Enterococci and other bacterial species, as well as modifying effects of the ZP2 peptide are required.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
GM-GSF活性中心合成类似物ZP2肽对肠球菌属细菌抗细胞因子活性及其产生细胞因子样物质能力的影响
肽ZP2是粒细胞-巨噬细胞集落刺激因子(GM-CSF)活性中心的合成类似物,具有广泛的免疫生物学作用,包括抗菌活性。与此同时,其对肠球菌(许多感染性和炎症性疾病的病原体)生物学特性的影响(在亚抑制浓度下)仍知之甚少。本研究的目的是分析合成肽ZP2对肠球菌抗细胞因子活性(ACA)及其产生细胞因子样物质(CLS)能力的影响。在实验中,菌株在含ZP2肽的Schaedlers肉汤中37℃培养24小时。对照组不添加特异性肽。ELISA法测定IL-8、TNF、IL-17A的ACA及相应CLS的产生。计算实验组相对于对照组的细胞因子失活比例,以pg/ml表示;通过实验和对照细胞因子水平来评价CLS的产生,以pg/ml表示。这些数据经过了统计处理。结果表明,肠球菌菌株能够分泌灭活细胞因子IL-8、IL-17A和TNF的化合物,并在培养基中产生CLS。在这些特性的存在和发生频率以及严重程度上,注意到种群内和种内的变异性。结果发现,粪肠中ZP2肽增加了所有研究细胞因子的ACA。当用粪肠球菌进行测试时,它要么不影响它们对TNF和IL-8的ACA,要么完全抑制IL-17A的ACA。同时,ZP2阻断了粪肠杆菌中IL-17A和IL-8等CLS的产生,但增加了与TNF相似的CLS的产生,并且在粪肠杆菌中,它使产生IL-17A的分离株的数量增加了两倍,尽管这些CLS的平均产量低于对照组。肠球菌菌株能够分泌灭活细胞因子IL-8、TNF和IL- 17A的化合物,并可能产生与这些细胞因子相似的物质。合成的肽ZP2对肠球菌的这些特性的表现具有修饰作用。需要进一步研究肠球菌和其他细菌的生物学和致病特性,以及ZP2肽的修饰作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
期刊最新文献
Effect of pregnancy-specific β1-glycoprotein on the expression of arginase-1 and indolamine-2,3-dioxygenase by myeloid-derived suppressor cells TLR-9 (-1237)*T/C polymorphism in russian COVID-19 patients from the chelyabinsk region Studies on the hormone and cytokine producing function of human cumulus cells and its interrelation with fertility in polycystic ovarian syndrome T helper subsets during the acute post-traumatic period in children Cytokine profile in adolescent children with recurrent infections and polypous rhinosinusitis, ways of their correction
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1